Modelling the Survival Outcomes of Immuno-Oncology Drugs in Economic Evaluations: A Systematic Approach to Data Analysis and Extrapolation
Author
Abstract
Suggested Citation
DOI: 10.1007/s40273-017-0558-5
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
References listed on IDEAS
- Patrick Royston & Paul C. Lambert, 2011. "Flexible Parametric Survival Analysis Using Stata: Beyond the Cox Model," Stata Press books, StataCorp LP, number fpsaus, March.
- Patrick Royston, 2001. "Flexible alternatives to the Cox model, and more," Stata Journal, StataCorp LP, vol. 1(1), pages 1-28, November.
Citations
Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
Cited by:
- Deborah Plana & Geoffrey Fell & Brian M. Alexander & Adam C. Palmer & Peter K. Sorger, 2022. "Cancer patient survival can be parametrized to improve trial precision and reveal time-dependent therapeutic effects," Nature Communications, Nature, vol. 13(1), pages 1-13, December.
- Bengt Jönsson & Grace Hampson & Jonathan Michaels & Adrian Towse & J.-Matthias Graf Schulenburg & Olivier Wong, 2019. "Advanced therapy medicinal products and health technology assessment principles and practices for value-based and sustainable healthcare," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 20(3), pages 427-438, April.
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.- Jackson, Christopher, 2016. "flexsurv: A Platform for Parametric Survival Modeling in R," Journal of Statistical Software, Foundation for Open Access Statistics, vol. 70(i08).
- Enzo Coviello, 2009. "Covariate-adjusted cumulative incidence in the presence of competing risks," Italian Stata Users' Group Meetings 2009 02, Stata Users Group.
- Patrick Royston, 2012. "Tools to simulate realistic censored survival-time distributions," Stata Journal, StataCorp LP, vol. 12(4), pages 639-654, December.
- Noori Akhtar-Danesh, 2015. "A Comparison of Modeling Scales in Flexible Parametric Models," 2015 Stata Conference 15, Stata Users Group.
- Enoch Yi-Tung Chen & Yuliya Leontyeva & Chia-Ni Lin & Jung-Der Wang & Mark S. Clements & Paul W. Dickman, 2024. "Comparing Survival Extrapolation within All-Cause and Relative Survival Frameworks by Standard Parametric Models and Flexible Parametric Spline Models Using the Swedish Cancer Registry," Medical Decision Making, , vol. 44(3), pages 269-282, April.
- Martin Gaksch & Rolf Jorde & Guri Grimnes & Ragnar Joakimsen & Henrik Schirmer & Tom Wilsgaard & Ellisiv B Mathiesen & Inger Njølstad & Maja-Lisa Løchen & Winfried März & Marcus E Kleber & Andreas Tom, 2017. "Vitamin D and mortality: Individual participant data meta-analysis of standardized 25-hydroxyvitamin D in 26916 individuals from a European consortium," PLOS ONE, Public Library of Science, vol. 12(2), pages 1-15, February.
- Talamas Marcos, Miguel Ángel, 2023. "Surviving Competition: Neighborhood Shops vs. Convenience Chains," IDB Publications (Working Papers) 13018, Inter-American Development Bank.
- Iversen, Tor & Ching-to , Albert Ma, 2020. "Technology Adoption in Primary Health Care," HERO Online Working Paper Series 2020:4, University of Oslo, Health Economics Research Programme.
- Patrick Royston, 2007. "Profile likelihood for estimation and confidence intervals," Stata Journal, StataCorp LP, vol. 7(3), pages 376-387, September.
- Herrera Dappe,Matias & Melecky,Martin & Turkgulu,Burak, 2022. "Fiscal Risks from Early Termination of Public-Private Partnerships in Infrastructure," Policy Research Working Paper Series 9972, The World Bank.
- Michael J. Crowther & Paul C. Lambert, 2012. "Simulating complex survival data," Stata Journal, StataCorp LP, vol. 12(4), pages 674-687, December.
- James P Cross & AustÄ— VaznonytÄ—, 2020. "Can we do what we say we will do? Issue salience, government effectiveness, and the legislative efficiency of Council Presidencies," European Union Politics, , vol. 21(4), pages 657-679, December.
- Martin Connock & Peter Auguste & Xavier Armoiry, 2021. "A comparison of published time invariant Markov models with Partitioned Survival models for cost effectiveness estimation; three case studies of treatments for glioblastoma multiforme," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 22(1), pages 89-100, February.
- Anne J Rerimoi & Momodou Jasseh & Schadrac C Agbla & Georges Reniers & Anna Roca & Ian M Timæus, 2019. "Under-five mortality in The Gambia: Comparison of the results of the first demographic and health survey with those from existing inquiries," PLOS ONE, Public Library of Science, vol. 14(7), pages 1-14, July.
- Paul Lambert, 2024. "Recent developments in the fitting and assessment of flexible parametric survival models," German Stata Conference 2024 01, Stata Users Group.
- Jonathan Karnon & Orla Caffrey & Clarabelle Pham & Richard Grieve & David Ben‐Tovim & Paul Hakendorf & Maria Crotty, 2013. "Applying Risk Adjusted Cost‐Effectiveness (Rac‐E) Analysis To Hospitals: Estimating The Costs And Consequences Of Variation In Clinical Practice," Health Economics, John Wiley & Sons, Ltd., vol. 22(6), pages 631-642, June.
- Paul Lambert, 2018. "Standardized survival curves and related measures from flexible survival parametric models," London Stata Conference 2018 14, Stata Users Group.
- Nan Liu, 2021. "Market buoyancy, information transparency and pricing strategy in the Scottish housing market," Urban Studies, Urban Studies Journal Limited, vol. 58(16), pages 3388-3406, December.
- Amin Moniri-Morad & Mohammad Pourgol-Mohammad & Hamid Aghababaei & Javad Sattarvand, 2019. "Reliability-based covariate analysis for complex systems in heterogeneous environment: Case study of mining equipment," Journal of Risk and Reliability, , vol. 233(4), pages 593-604, August.
- Patricia Guyot & Anthony E. Ades & Matthew Beasley & Béranger Lueza & Jean-Pierre Pignon & Nicky J. Welton, 2017. "Extrapolation of Survival Curves from Cancer Trials Using External Information," Medical Decision Making, , vol. 37(4), pages 353-366, May.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:pharme:v:35:y:2017:i:12:d:10.1007_s40273-017-0558-5. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .
Please note that corrections may take a couple of weeks to filter through the various RePEc services.